These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 26905133)

  • 21. Surgical experience with nonfunctioning neuroendocrine tumors of the pancreas.
    Matthews BD; Heniford BT; Reardon PR; Brunicardi FC; Greene FL
    Am Surg; 2000 Dec; 66(12):1116-22; discussion 1122-3. PubMed ID: 11149582
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Clinical characteristics and malignant predictive factors of pancreatic neuroendocrine tumors].
    Han JH; Kim MH; Moon SH; Park SJ; Park DH; Lee SS; Seo DW; Lee SK; Kim SC; Han DJ
    Korean J Gastroenterol; 2009 Feb; 53(2):98-105. PubMed ID: 19237835
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pancreatic neuroendocrine tumors: A single-center 20-year experience with 100 patients.
    Shiba S; Morizane C; Hiraoka N; Sasaki M; Koga F; Sakamoto Y; Kondo S; Ueno H; Ikeda M; Yamada T; Shimada K; Kosuge T; Okusaka T
    Pancreatology; 2016; 16(1):99-105. PubMed ID: 26718527
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Surgical experience with pancreatic and peripancreatic neuroendocrine tumors: review of 125 patients.
    Phan GQ; Yeo CJ; Hruban RH; Lillemoe KD; Pitt HA; Cameron JL
    J Gastrointest Surg; 1998; 2(5):472-82. PubMed ID: 9843608
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Critical appraisal of 232 consecutive distal pancreatectomies with emphasis on risk factors, outcome, and management of the postoperative pancreatic fistula: a 21-year experience at a single institution.
    Goh BK; Tan YM; Chung YF; Cheow PC; Ong HS; Chan WH; Chow PK; Soo KC; Wong WK; Ooi LL
    Arch Surg; 2008 Oct; 143(10):956-65. PubMed ID: 18936374
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Treatment Strategy for Non-Functional Pancreatic Neuroendocrine Tumors (P-NETs) at Kurume University Hospital].
    Kawashima Y; Ishikawa H; Hisaka T; Okuda K; Akagi Y
    Gan To Kagaku Ryoho; 2016 Jan; 43(1):107-10. PubMed ID: 26809536
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Clinicopathological features and multivariate analysis of prognostic factors for patients with gastroenteropancreatic neuroendocrine tumors].
    Wang X; Song ZF; Yao WX; Pan CC; Xiang MF; Wang H
    Zhonghua Yi Xue Za Zhi; 2013 May; 93(18):1411-4. PubMed ID: 24025507
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Analysis of risk factors for recurrence after curative resection of well-differentiated pancreatic neuroendocrine tumors based on the new grading classification.
    Tsutsumi K; Ohtsuka T; Fujino M; Nakashima H; Aishima S; Ueda J; Takahata S; Nakamura M; Oda Y; Tanaka M
    J Hepatobiliary Pancreat Sci; 2014 Jun; 21(6):418-25. PubMed ID: 24142395
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Clinicopathological features of pancreatic neuroendocrine neoplasms: a retrospective analysis of 64 cases].
    Yao W; Wang W; Li G
    Zhonghua Zhong Liu Za Zhi; 2014 Apr; 36(4):287-93. PubMed ID: 24989916
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prognostic factors and survival in endocrine tumor patients: comparison between gastrointestinal and pancreatic localization.
    Panzuto F; Nasoni S; Falconi M; Corleto VD; Capurso G; Cassetta S; Di Fonzo M; Tornatore V; Milione M; Angeletti S; Cattaruzza MS; Ziparo V; Bordi C; Pederzoli P; Delle Fave G
    Endocr Relat Cancer; 2005 Dec; 12(4):1083-92. PubMed ID: 16322345
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Pancreatic cancer surgery at Ist Surgical Clinic of the Olomouc Faculty Hospital (FN Olomouc)].
    Lovecek M; Neoral C; Klos D; Skalický P; Kysucan J; Vrba R; Melichar B; Svébisová H; Tozzi di Angelo I; Kliment M; Havlík R
    Rozhl Chir; 2010 Dec; 89(12):731-9. PubMed ID: 21404512
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Lymph node sampling rates and predictors of nodal metastasis in pancreatic neuroendocrine tumor resections: the UCSF experience with 149 patients.
    Parekh JR; Wang SC; Bergsland EK; Venook AP; Warren RS; Kim GE; Nakakura EK
    Pancreas; 2012 Aug; 41(6):840-4. PubMed ID: 22781907
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Surgical management of insulinomas: short- and long-term outcomes after enucleations and pancreatic resections.
    Crippa S; Zerbi A; Boninsegna L; Capitanio V; Partelli S; Balzano G; Pederzoli P; Di Carlo V; Falconi M
    Arch Surg; 2012 Mar; 147(3):261-6. PubMed ID: 22430908
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Surgical management of advanced pancreatic neuroendocrine tumors: short-term and long-term results from an international multi-institutional study.
    Birnbaum DJ; Turrini O; Vigano L; Russolillo N; Autret A; Moutardier V; Capussotti L; Le Treut YP; Delpero JR; Hardwigsen J
    Ann Surg Oncol; 2015 Mar; 22(3):1000-7. PubMed ID: 25190116
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Analysis of diagnosis and treatment for pancreatic neuroendocrine neoplasms: results of 47 cases in a single institution.
    Lin XS; Zhu CL; Liu CH; Xie F; Zhou HC; Huang Q
    Hepatogastroenterology; 2014; 61(136):2383-6. PubMed ID: 25699387
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Survival following resection of pancreatic endocrine tumors: importance of R-status and the WHO and TNM classification systems.
    Pomianowska E; Gladhaug IP; Grzyb K; Røsok BI; Edwin B; Bergestuen DS; Mathisen O
    Scand J Gastroenterol; 2010 Aug; 45(7-8):971-9. PubMed ID: 20441530
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evaluation of surgical resection for pancreatic carcinoma at a Japanese single cancer institute.
    Nanashima A; Tobinaga S; Abo T; Hatano K; Takeshita H; Nonaka T; Hidaka S; Tanaka K; Kunizaki M; Sawai T; Yasutake T; Nagayasu T
    Hepatogastroenterology; 2012 May; 59(115):911-5. PubMed ID: 22469741
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Tumor-positive resection margins reflect an aggressive tumor biology in pancreatic cancer.
    Kimbrough CW; St Hill CR; Martin RC; McMasters KM; Scoggins CR
    J Surg Oncol; 2013 May; 107(6):602-7. PubMed ID: 23450687
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical and pathological features of five-year survivors after pancreatectomy for pancreatic adenocarcinoma.
    Kimura K; Amano R; Nakata B; Yamazoe S; Hirata K; Murata A; Miura K; Nishio K; Hirakawa T; Ohira M; Hirakawa K
    World J Surg Oncol; 2014 Nov; 12():360. PubMed ID: 25429841
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Relapse-free survival in patients with nonmetastatic, surgically resected pancreatic neuroendocrine tumors: an analysis of the AJCC and ENETS staging classifications.
    Strosberg JR; Cheema A; Weber JM; Ghayouri M; Han G; Hodul PJ; Kvols LK
    Ann Surg; 2012 Aug; 256(2):321-5. PubMed ID: 22415420
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.